A new study suggests that an epilepsy drug could help alleviate symptoms of obstructive sleep apnoea, a common condition affecting about 5% of people. Presented at the European Respiratory Society Congress in Vienna, the research indicates that the drug sulthiame may significantly reduce breathing interruptions and improve oxygen levels during sleep. Obstructive sleep apnoea, which causes frequent interruptions in breathing during sleep, is often treated with mechanical devices like CPAP machines. However, many patients struggle with these devices, prompting the search for alternative treatments. The international study involved nearly 300 patients across Belgium, the Czech Republic, France, Germany, and Spain, who were either given sulthiame at varying doses or a placebo. After 12 weeks, those on sulthiame experienced up to 50% fewer breathing pauses and higher blood oxygen levels compared to those on the placebo. The most significant benefits were observed with the highest doses of the drug. Source: Oman News Agency
Related Articles
IMF Mission Highlights Strong Economic Growth and Future Outlook for Oman
Muscat: The meetings of the International Monetary Fund (IMF) experts mission to the Sultanate of Oman, within the framework of the 2025 Article IV Consultations, concluded in Muscat. During these meetings, discussions were held with government offici…
MSX Climbs 54 Points as Trading Value Declines
Muscat: The MSX 30 Index concluded today’s session at 5,915.73 points, gaining 54.9 points, or 0.94 percent, compared to the previous close of 5,860.80 points.
According to Oman News Agency, the total trading value reached RO 40,769,158, reflecting…
Jordan implements gradual export restrictions on tomatoes amid price surge
Amman, Khaled Hneifat, Jordan’s Minister of Agriculture, announced a policy to restrict tomato export and increase imports to local markets. This gradual approach will continue until exports are halted if the current trend of decreasing tomato imports…
